Aurobindo Pharma Limited has reported Consolidated financial results for the period ended June 30, 2023.

Aurobindo Pharma has posted net profit of Rs. 570.75 crores for the period ended June 30, 2023 as against net profit of Rs. 506.27 crores for the period ended March 31, 2023. The company posted net profit of Rs.520.54 crores for the period ended June 30, 2022.

Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023 as compared to Rs. 6607.87 crores during the period ended March 31, 2023. The company reported total income of Rs.6276.54 crores during the period ended June 30, 2022.